Development of a new guinea-pig model of shigellosis

FEMS Immunology and Medical Microbiology

Volumn 62, Issue 3, 2011, Pages 304-314

  Barman, Soumik ^a   Saha, Dhira Rani ^a   Ramamurthy, Thandavarayan ^a   Koley, Hemanta ^a  

^a NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Luminal inoculation; Protective efficacy; Shigella; Shigellosis model

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; COLON HEMORRHAGE; CONTROLLED STUDY; DESCENDING COLON; DYSENTERY; EXPERIMENTAL INFECTION; FEMALE; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI; SHIGELLOSIS; WEIGHT REDUCTION;

ANIMALS; COLON; DISEASE MODELS, ANIMAL; DYSENTERY, BACILLARY; GUINEA PIGS; HISTOCYTOCHEMISTRY; REPRODUCIBILITY OF RESULTS; SHIGELLA DYSENTERIAE; SHIGELLA FLEXNERI;

EID: 79960364544     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00810.x     Document Type: Article

References (32)

1. Anand BS, Malhotra V, Bhattacharya SK et al. (1986) Rectal histology in acute bacillary dysentery. Gastroenterology 90: 654-660.
2. Chakrabarti MK, Bhattacharya J, Bhattacharya MK, Nair GB, Bhattacharya SK & Mahalanabis D (1999) Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in the rabbit model of shigellosis. Acta Paediatr 88: 161-165.
3. Chen Y, Smith MR, Thirumalai K & Zychlinsky A (1996) A bacterial invasion induces macrophage apoptosis by binding directly to ICE. EMBO J 15: 3853-3860.
4. Collins TA, Barnoy S, Baqar S, Ranallo RT, Nemelka KW & Venkatesan MM (2008) Safety and colonization of two novel VirG (IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta). Comp Med 58: 88-94.
5. Cossart P & Sansonetti PJ (2004) Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 304: 242-248.
6. Dubois M, Gilles KA, Hamilton JK, Rebers PA & Smith F (1956) Colorimetric method for determination of sugars and related substances. Anal Chem 28: 350-356.
7. Fernandez MI, Thuizat A, Pedron T, Neutra M, Phalipon A & Sansonetti PJ (2003) A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell Microbiol 5: 481-491.
8. Formal SB, Dammin GJ, Labrec EH & Schneider H (1958) Experimental Shigella infections: characteristics of a fatal infection produced in guinea pigs. J Bacteriol 75: 604-610.
9. Hartman AB, Powell CJ, Schultz CL, Oaks EV & Eckels KH (1991) Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains. Infect Immun 59: 4075-4083.
10. Jeong KI, Zhang Q, Nunnari J & Tzipori S (2010) A piglet model of acute gastroenteritis induced by Shigella dysenteriae Type 1. J Infect Dis 201: 903-911.
11. Keren DF (1979) Enzyme-linked immunosorbent assay for immunoglobulin G and immunoglobulin A antibodies to Shigella flexneri antigens. Infect Immun 24: 441-448.
12. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK & Levine MM (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. B World Health Organ 77: 651-666.
13. Levine MM, Kotloff KL, Barry EM, Pasetti MF & Sztein MB (2007) Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 5: 540-553.
14. Lin FC, Yang TL & Yeh SH (1964) Experimental keratoconjunctivitis shigellosis in guinea pigs. I. Immune phenomenon and antibody formation. Chin Med J 83: 454-462.
15. Mallett CP, Hale TL, Kaminski RW, Larsen T, Orr N, Cohen D & Lowell GH (1995) Intranasal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection. Infect Immun 63: 2382-2386.
16. Orr N, Robin G, Cohen D, Arnon R & Lowell GH (1993) Immunogenicity and efficacy of oral or intranasal Shigella flexneri 2a and Shigella sonnei proteosome-lipopolysaccharide vaccines in animal models. Infect Immun 61: 2390-2395.
17. Perdomo JJ, Gounon P & Sansonetti PJ (1994) Polymorphonuclear leukocyte transmigration promotes invasion of colonic epithelial monolayer by Shigella flexneri. J Clin Invest 93: 633-643.
18. Phalipon A & Sansonetti PJ (2003) Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development. Crit Rev Immunol 23: 371-401.
19. Phalipon A & Sansonetti PJ (2007) Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol 85: 119-129.
20. Phalipon A, Mulard LA & Sansonetti PJ (2008) Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path? Microbes Infect 10: 1057-1062.
21. Rabbani GH, Albert MJ, Rahman H, Islam M, Mahalanabis D, Kabir I, Alam K & Ansaruzzaman M (1995) Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a. Infect Immun 63: 4350-4357.
22. Robbins JB, Chu C & Schneerson R (1992) Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides. Clin Infect Dis 15: 346-361.
23. Rout WR, Formal SB, Giannella RA & Dammin GJ (1975) Pathophysiology of Shigella diarrhea in the rhesus monkey: intestinal transport, morphological, and bacteriological studies. Gastroenterology 68: 270-278.
24. Saatman RA, Carlton WW, Hubben K, Streett CS, Tuckosh JR & DeBaecke PJ (1986) A wound healing study of chlorhexidine digluconate in guinea pigs. Fund Appl Toxicol 6: 1-6.
25. Sack RB, Kline RL & Spira WM (1988) Oral immunization of rabbits with enterotoxigenic Escherichia coli protects against intraintestinal challenge. Infect Immun 56: 387-394.
26. Sansonetti PJ (2006) The bacterial weaponry: lessons from Shigella. Ann NY Acad Sci 1072: 307-312.
27. Sereny B (1955) Experimental Shigella keratoconjunctivitis; a preliminary report. Acta Microbiol Hung 2: 293-296.
28. Shim DH, Suzuki T, Chang SY, Park SM, Sansonetti PJ, Sasakawa C & Kweon MN (2007) New animal model of shigellosis in the Guinea pig: its usefulness for protective efficacy studies. J Immunol 178: 2476-2482.
29. Slauch JM, Mahan MJ, Michetti P, Neutra MR & Mekalanos JJ (1995) Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen. Infect Immun 63: 437-441.
30. Sur D, Lopez AL & Kanungo S (2009) Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet 374: 1694-1702.
31. Takeuchi A, Formal SB & Sprinz H (1968) Experimental acute colitis in the Rhesus monkey following peroral infection with Shigella flexneri: an electron microscope study. Am J Pathol 52: 503-529.
32. Voino-Yasenetsky MV & Voino-Yasenetskaya MK (1962) Experimental pneumonia caused by bacteria of the Shigella group. Acta Morphol Hung 11: 439-454.